Fact.MR, a market research and competitive intelligence provider, reveals that the global oral thin films market is worth US$ 3.12 billion in 2022 and is expected to surge ahead at an impressive CAGR of 8.7% during the forecast years of 2022-2032.
The oral route is the most popular for therapeutic administration because of its low cost and easy availability. Mainly, the solid form of oral drugs is available in tablets and capsules. This poses difficulties in swallowing for geriatric and paediatric patients. Oral thin films improve patients’ compliance by enhancing the drug administration for them. They also aid psychiatric and bedridden patients who otherwise refuse to swallow tablets and capsules. Addressing these challenges has catalysed the rapid adoption of oral thin films in the pharmaceutical sector.
Download Free Sample Copy of This Report:
The characteristics of oral thin films, such as dosage flexibility and ease of administration, attracts users. Oral thin films are also fast-acting and prompt drugs that enter the circulatory system through direct absorption, and even reduce the risk of choking. Furthermore, no special training is required for their administration.
As oral thin films are moisture-sensitive, they require special packaging. Focusing on product innovation and packaging techniques can help manufacturers reduce costs and product damage.
Key Takeaways from Market Study
- The global oral thin films market is set to expand at a CAGR of 8.7% and reach US$ 7,187.1 million by the end of 2032.
- The market evolved at 6.1% CAGR between 2017 and 2021.
- Under product vertical, the orodispersable segment is estimated to be valued at US$ 1.92 billion in 2022.
- North America is the leading regional market with 60.3% share in 2021.
- Consumption of oral thin films is expected to increase at CAGRs of 12.5% and 24.2%, respectively, in Latin America and the Middle East and Africa.
“Surging adoption of novel oral thin films among geriatric & pediatric population boosting market value,” says a Fact.MR analyst.
At the introductory stage, oral thin film manufacturers have their focus on product innovation and development. Strong investments in research and development to address the existing limitations of oral thin film s, such as limited drug load and load of water-insoluble drugs, have led to several product launches and approval requests in the market.
Leaders in the oral thin films market are majorly investing in technological innovation and strategic expansion. Securing license agreement to boost international sales is also a key challenge.
Some of the leading players include
- Indivior Plc.
- Aquestive Therapeutics Inc.
- LIVKON Pharmaceuticals Pvt. Ltd.
- Sunovion Pharmaceuticals Inc.
- NAL Pharma
- CURE Pharmaceutical
- IntelGenx Corp.
- Kyu Pharmaceutical Co. Ltd.
- C.L. Pharm
Speak to Analyst:
- By Product Type :
- Sublingual Film
- Buccal Film
- By Indication :
- Pain Management
- Neurological Disorders
- Nausea & Vomiting
- Opioid Dependence
- By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region :
- North America
- Latin America
- East Asia
- South Asia & ASEAN
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global oral thin films market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.
The study reveals essential insights on the basis of product type (oromucosal, orodispersible), indication (pain management, neurological disorders, nausea & vomiting, opioid dependence, others), and distribution channel (hospital pharmacies, retail pharmacies, online pharmacies), across major regions of the world (North America, Latin America, Europe, East Asia, South Asia & ASEAN, Oceania, and the Middle East & Africa).
Get Full Access of this Report through our PayPal Payment Gateway
Explore Fact.MR’s Healthcare Reports
Rapid Oral Fluid Screening Devices Market– The rapid oral fluid screening devices market registered growth at a CAGR of over 4% during the period, 2013–2017. The growth rate of rapid oral fluid screening devices market can be attributed to a cohort of factors, such as growing alcohol & drug consumption.
Drug Delivery Systems Market– The worldwide drug delivery systems market was worth around US$ 40 Billion in 2022 and is expected to grow at a CAGR of more than 7.8% from 2022 to 2032, reaching roughly US$ 80 Billion by 2032.
Echocardiography Market – The global echocardiography market size is likely to reach over US$ 2 billion by 2031, registering a note worthy growth rate over the next ten years. Rapid penetration of key technological advancements, including AI and machine learning, has served to heighten the growth prospects of market players.
Drug-Loaded Oral Thin Films Market: As per Fact.MR, the global demand for drug-loaded oral thin films is expected to grow at a significant pace during the forecast period owing to their rapid absorption rate, faster action, and biocompatibility.
Carrier screening Market– Increasing awareness about the increasing transfer of genetic diseases is being witnessed in the healthcare industry, amongst end-users. In response to this, end-users have become more cautious, with an intention of detecting and preventing these diseases at its early stage.
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
US Sales Office:
11140 Rockville Pike
Rockville, MD 20852
Tel: +1 (628) 251-1583